Intravenous pulse cyclophosphamide therapy in myositis and Sjögren's syndrome

J P Leroy; A A Drosos; D I Yiannopoulos; P Youinou; H M Moutsopoulos

doi:10.1002/art.1780331017

Intravenous pulse cyclophosphamide therapy in myositis and Sjögren's syndrome

Arthritis Rheum. 1990 Oct;33(10):1579-81. doi: 10.1002/art.1780331017.

Authors

J P Leroy¹, A A Drosos, D I Yiannopoulos, P Youinou, H M Moutsopoulos

Affiliation

¹ Laboratory of Pathology, Brest University Medical School, France.

PMID: 2222539
DOI: 10.1002/art.1780331017

Abstract

We describe a patient with primary Sjögren's syndrome who developed myositis. The results of muscle pathologic analysis before and after treatment with monthly pulses of cyclophosphamide (intravenously), are presented.

Publication types

Case Reports
Research Support, Non-U.S. Gov't

MeSH terms

Aged
Biopsy
Cyclophosphamide / administration & dosage
Cyclophosphamide / therapeutic use*
Female
Humans
Injections, Intravenous
Muscles / drug effects
Muscles / pathology
Myositis / drug therapy*
Sjogren's Syndrome / drug therapy*

Substances

Cyclophosphamide